Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CHH | CRGY |
|---|---|---|
| Price | $99.58 | $13.56 |
| Change today | ▼ 2.85% | ▲ 1.27% |
| Market cap | $4.48B | $4.48B |
| Return, 3 months | -10.0% | +45.5% |
| Return, year to date | +5.7% | +66.4% |
| Return, 1 year | -3.1% | +54.3% |
| P/E (TTM) | 14.1 | 169.5 |
| P/B | 31.5 | 0.9 |
| P/E percentile vs own 5y | 10th | 99th |
| Dividend yield | 1.15% | 3.54% |
| Revenue growth (YoY, latest qtr) | +3.4% | – |
| Net profit growth (YoY) | -21.3% | – |
| Gross margin | 49.4% | – |
| Operating margin | 23.7% | – |
| Net margin | 14.6% | – |
| Return on equity | – | – |
| Analyst target vs. price | +14.2% | +32.7% |
| Analyst buy share | 20% | 83% |
| RSI (14) | 44 | 53 |
| 30-day volatility | 29.0% | 38.5% |
| Max drawdown, 1 year | -23.7% | -33.7% |
| Trend read | Strong downtrend | Leaning bullish |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
